Sign in
CompletedNo phase

Assessment of the Adjuvant Role of Dietary Supplementation of Antibiotic-tolerant Probiotics in Standard Therapy for the Eradication of Helicobacter Pylori Infection.

Key facts

Who runs it
IBSA Farmaceutici Italia Srl
Where
Italy1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
270 people enrolled
Started
3 Jul 2024
Ended
5 May 2025
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • IBSA Probiotics
  • Placebo
Record updated
8 July 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Diagnosis of H. pylori infection by breath test and histological and/or cultural examination on biopsy (performed within 10 days prior to T0)
  • Prescription of eradication therapy for HP
  • Naïve patients (who have never had eradication therapy for H. pylori)
  • Patients with symptoms of upper gastrointestinal tract
  • Obtaining informed consent

Who cannot take part

  • Patients with history of previous eradication attempts
  • Patients with known gastric disease (e.g. atrophic gastritis, gastric cancer)
  • Patients with severe organ dysfunction (cirrhosis of the liver, severe renal or respiratory failure, dialysis)
  • Women who are pregnant or breastfeeding
  • Patients unable to provide informed consent

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Randomized, double-blind, placebo-controlled clinical study to assess the adjuvant role of dietary supplementation of antibiotic-tolerant probiotics, derived from Lactobacillus acidophilus and Bifidobacterium animalis, in standard therapy for the eradication of Helicobacter pylori infection.

The 2 groups in the trial

  • Control groupPlacebo, for comparison

    Patients under H. pylori eradication therapy and placebo as treatment

    Treatment: Placebo

  • Treated groupTreatment being tested

    Patients under H. pylori eradication therapy and probiotics as treatment

    Treatment: IBSA Probiotics

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Randomized, Double-blind, Placebo-controlled Clinical Study to Assess the Adjuvant Role of Dietary Supplementation of Antibiotic-tolerant Probiotics in Standard Therapy for the Eradication of Helicobacter Pylori Infection.
Record updated
8 July 2025